Treatment of Functioning Adrenaloma
Complete surgical resection (R0 resection) via adrenalectomy is the definitive treatment for functioning adrenalomas, as it provides the only means to achieve long-term cure and resolution of hormone excess. 1
Preoperative Hormonal Management
Before proceeding to surgery, meticulous perioperative management of hormonal abnormalities is critical to prevent complications 1:
For cortisol-producing adenomas: Patients require postoperative corticosteroid supplementation (hydrocortisone or prednisone) until recovery of the hypothalamus-pituitary-adrenal axis, which may take months 1
For pheochromocytomas: Alpha-adrenergic blockade must be initiated preoperatively to prevent hypertensive crisis during surgery 2, 3
For aldosteronomas: Medical management with spironolactone (400-1200 mg/day) can be used preoperatively to control hypertension and hypokalemia 1, 4
Surgical Approach Selection
The choice of surgical technique depends on tumor characteristics 1:
Laparoscopic adrenalectomy is the preferred approach for:
Open adrenalectomy is required for:
Center Selection
Adrenal surgery should only be performed in specialized centers performing >10 adrenalectomies for adrenal cancer per year 1
Expected Outcomes
Surgical cure rates for functioning tumors are excellent 5:
- Pheochromocytomas: 100% resolution of clinical and biochemical hyperfunction when completely resected 5
- Aldosteronomas: 96% biochemical cure, though 72% may require continued antihypertensive medication for improved blood pressure control 5
- Cortisol-producing adenomas: 100% resolution of hormonal excess 5
Postoperative Follow-up
After complete resection, regular surveillance is mandatory 1:
- Biochemical testing at 14 days post-surgery to confirm complete resection 2
- For pheochromocytomas: Plasma or urinary metanephrines every 3-4 months for 2-3 years, then every 6 months, with lifelong surveillance recommended 1, 2
- For adrenocortical carcinoma: Abdominal CT/MRI and chest CT every 3 months for 2 years, then gradually increased intervals for at least 10 years 1
- Imaging studies should be performed if new symptoms develop or biochemical markers become elevated 1, 2
Special Considerations
High-risk features requiring more aggressive follow-up include 1, 2:
- Tumor size >5 cm
- Extra-adrenal location (paragangliomas)
- SDHB germline mutations
- Elevated plasma methoxytyramine (>3x upper limit)
Common pitfall: Failure to provide adequate corticosteroid replacement after resection of cortisol-producing adenomas can lead to life-threatening adrenal crisis 1